FRANCIS RICHARD D (President and CEO) sold 1.7% of their position (20.02K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $634.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001193125-26-098551
Officer· President and CEO
Since Mar 2026
-20.02K
Net shares
Net seller
$634.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
42.45K acquired · 62.48K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+42.45K
Price / share
—
Trade value
—
% of position
3.7%
3/5/2026
1.15M→1.19M
Ordinary Shares
Direct
Shares
−20.02K
Price / share
$31.67
Trade value
$634.16K
% of position
1.7%
3/5/2026
1.19M→1.17M
Total
Net shares
+22.43K
Net value
-$634.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/5/2026 | M · Option Exercise | +42.45K | — | — | 3.7% | 1.15M | 1.19M |
| Ordinary Shares Direct | 3/5/2026 | S · Sale | −20.02K | $31.67 | $634.16K | 1.7% | 1.19M | 1.17M |
| Total | +22.43K | -$634.16K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
42.45K shares
Shares
−42.45K
Strike price
Held after
127.36K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares42.45K shares | 3/5/2026 | M · Option Exercise | −42.45K | — | 127.36K |